article out of the us, page-3

DMA

According to Hayden antivirals is the way to go and it doesn't matter what we do, will still come to a shortfall situation.

http://www.uvamagazine.org/site/c.esJNK1PIJrH/b.1601297/k.6733/Once_and_Future_Plague.htm

So, I wish Stout go and take a hike, if Stout do not put these hurdles in front of Relenza, I reckon we will be selling at least 10 times as much Relenza by now and Biota will be trading on a PE of 4 on current prices.